Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
B&G Foods
BGS
$290M
| $14.6M | ﹤0.01% |
1,473,347
+53,177
| +4% | +$659K |
|
2027
Regenxbio
RGNX
$638M
| $14.5M | ﹤0.01% |
883,146
+69,617
| +9% | +$1.26M |
|
2028
Centrus Energy
LEU
$3.63B
| $14.5M | ﹤0.01% |
255,383
+13,938
| +6% | +$600K |
|
|
VISN
2029
Vistance Networks Inc
VISN
$2.72B
| $14.5M | ﹤0.01% |
4,313,523
+107,237
| +3% | +$439K |
|
|
DCPH
2030
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $14.5M | ﹤0.01% |
1,136,607
+27,202
| +2% | +$375K |
|
2031
RxSight
RXST
$260M
| $14.5M | ﹤0.01% |
518,139
+66,320
| +15% | +$1.98M |
|
2032
Kura Oncology
KURA
$816M
| $14.4M | ﹤0.01% |
1,577,956
+249,840
| +19% | +$2.54M |
|
2033
CRA International
CRAI
$1.16B
| $14.4M | ﹤0.01% |
142,790
+4,420
| +3% | +$464K |
|
2034
Bank First Corp
BFC
$1.72B
| $14.4M | ﹤0.01% |
186,373
+8,172
| +5% | +$669K |
|
|
LGF.A
2035
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $14.4M | ﹤0.01% |
1,694,918
+98,910
| +6% | +$786K |
|
2036
Skyward Specialty Insurance
SKWD
$2.47B
| $14.4M | ﹤0.01% |
524,955
+322,813
| +160% | +$8.04M |
|
2037
Usana Health Sciences
USNA
$422M
| $14.3M | ﹤0.01% |
244,719
+11,371
| +5% | +$711K |
|
2038
Bank of N.T. Butterfield & Son
NTB
$2.46B
| $14.3M | ﹤0.01% |
528,377
+30,092
| +6% | +$876K |
|
2039
West Fraser Timber
WFG
$5.2B
| $14.3M | ﹤0.01% |
197,670
-13,786
| -7% | -$1.08M |
|
2040
Titan International
TWI
$466M
| $14.3M | ﹤0.01% |
1,061,097
+39,484
| +4% | +$482K |
|
2041
Clean Energy Fuels
CLNE
$410M
| $14.2M | ﹤0.01% |
3,713,076
+222,652
| +6% | +$992K |
|
|
INN
2042
Summit Hotel Properties
INN
$749M
| $14.2M | ﹤0.01% |
2,447,343
+100,734
| +4% | +$601K |
|
2043
Alpha and Omega Semiconductor
AOSL
$942M
| $14.2M | ﹤0.01% |
475,437
+14,011
| +3% | +$436K |
|
2044
Protolabs
PRLB
$1.92B
| $14.1M | ﹤0.01% |
535,817
+15,234
| +3% | +$460K |
|
|
EQRX
2045
DELISTED
EQRx, Inc. Common Stock
EQRX
| $14.1M | ﹤0.01% |
6,371,086
+500,026
| +9% | +$1.07M |
|
2046
Editas Medicine
EDIT
$407M
| $14.1M | ﹤0.01% |
1,807,979
+315,156
| +21% | +$2.7M |
|
2047
Rocket Companies
RKT
$38.7B
| $14M | ﹤0.01% |
1,715,329
+17,006
| +1% | +$172K |
|
|
INFA
2048
DELISTED
Informatica
INFA
| $14M | ﹤0.01% |
665,863
+11,898
| +2% | +$237K |
|
2049
MarineMax
HZO
$774M
| $14M | ﹤0.01% |
427,372
+1,788
| +0.4% | +$62.2K |
|
|
NVRO
2050
DELISTED
NEVRO CORP.
NVRO
| $14M | ﹤0.01% |
729,574
+27,869
| +4% | +$594K |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.